-The Telegraph   The Supreme Court today asked the Centre to ensure that drug prices go down, not up, if and when a new price control policy comes into force. “Prices may go down but should not go up because of policy,” Justice S.J. Mukhopadhyay, sitting alongside senior judge G.S. Singhvi, said. “Bring it down, don’t escalate it in the name of policy,” the bench told additional solicitor-general Parag Tripathi, who was speaking...

-The Hindu   A Central team of the National Rural Health Mission (NRHM) has praised the implementation of various health care and nutrition schemes in Rajasthan and expressed hope that the constant decline in infant and maternal mortality rates would help improve the status of health indicators in the State. The 12-member team, divided into two sub-groups, visited Chittorgarh and Barmer districts and reviewed the progress of initiatives taken under the NRHM, mid-day...

India’s new pharmaceutical policy seeks to bring at least 400 essential medicines—or 60% of the drugs sold in the country—under the government’s pricing control. The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing. Currently, the government controls the prices of only 34 essential medicines. The draft says the policy, to be finalized...

With institutional healthcare being prohibitively expensive, more women in rural India are choosing to deliver at home than in hospitals and healthcare facilities, says a new report brought out by Chittorgarh-based NGO, Prayas, in partnership with Oxfam India. The 'Study of the trends in out-of-pocket payments in healthcare during National Rural Health Mission period (2005-2010)', released on October 12 in the national capital, was conducted across five Indian states - Assam,...

-The Business Standard   It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...